PCVX
Price
$33.65
Change
+$1.51 (+4.70%)
Updated
Sep 26, 04:47 PM (EDT)
Capitalization
4.17B
45 days until earnings call
TSHA
Price
$3.25
Change
+$0.19 (+6.21%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
834.75M
47 days until earnings call
Interact to see
Advertisement

PCVX vs TSHA

Header iconPCVX vs TSHA Comparison
Open Charts PCVX vs TSHABanner chart's image
Vaxcyte
Price$33.65
Change+$1.51 (+4.70%)
Volume$8.1K
Capitalization4.17B
Taysha Gene Therapies
Price$3.25
Change+$0.19 (+6.21%)
Volume$67.08K
Capitalization834.75M
PCVX vs TSHA Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. TSHA commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a StrongBuy and TSHA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (PCVX: $32.14 vs. TSHA: $3.06)
Brand notoriety: PCVX and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 159% vs. TSHA: 65%
Market capitalization -- PCVX: $4.17B vs. TSHA: $834.75M
PCVX [@Biotechnology] is valued at $4.17B. TSHA’s [@Biotechnology] market capitalization is $834.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • PCVX’s TA Score: 3 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both PCVX and TSHA are a bad buy in the short-term.

Price Growth

PCVX (@Biotechnology) experienced а -1.38% price change this week, while TSHA (@Biotechnology) price change was +2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 10, 2025.

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.17B) has a higher market cap than TSHA($835M). TSHA YTD gains are higher at: 76.879 vs. PCVX (-60.738). TSHA has higher annual earnings (EBITDA): -91.48M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. TSHA (313M). TSHA has less debt than PCVX: TSHA (59.6M) vs PCVX (85.8M). TSHA has higher revenues than PCVX: TSHA (8.1M) vs PCVX (0).
PCVXTSHAPCVX / TSHA
Capitalization4.17B835M500%
EBITDA-584.35M-91.48M639%
Gain YTD-60.73876.879-79%
P/E RatioN/A2.70-
Revenue08.1M-
Total Cash1.66B313M531%
Total Debt85.8M59.6M144%
TECHNICAL ANALYSIS
Technical Analysis
PCVXTSHA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPMMX17.28N/A
N/A
Reinhart Mid Cap PMV Inv
IEFCX25.77N/A
N/A
Invesco Energy C
FRSIX18.34N/A
N/A
Franklin Small-Mid Cap Growth C
KNPYX127.90N/A
N/A
Kinetics Paradigm Instl
CAFEX43.36-0.36
-0.82%
American Funds AMCAP 529E

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with MIST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.07%
MIST - PCVX
52%
Loosely correlated
+1.55%
KYMR - PCVX
47%
Loosely correlated
+2.35%
NUVL - PCVX
47%
Loosely correlated
-2.54%
BEAM - PCVX
46%
Loosely correlated
-2.12%
TSHA - PCVX
46%
Loosely correlated
-2.86%
More